Bethany Rhoten, PhD, RN, associate professor at Vanderbilt School of Nursing, discusses sexuality after treatment of head and neck cancer and how healthcare providers can help their patients communicate quality of life issues.
Oncology Nurse Fiona McCaughan on Struggles Facing Intraperitoneal Ovarian Cancer Treatments
Kenneth Freundlich, neuropsychologist, Morris Psychological Group, Parsippany, NJ, discusses the need to support patients with hereditary cancers.
I will never forget the emotions – mostly disbelief and fear – that arose when I arrived at the cancer center.
Kilian Salerno, director of Breast Radiation and Soft Tissue/Melanoma Radiation, Roswell Park Cancer Center, discusses assessing cancer risk.
Vassiliki A. Papadimitrakopoulou, MD was honored at the 19th Annual International Lung Cancer Congress.
Christian Nelson, PhD, Memorial Sloan Kettering Cancer Center, discusses Memorial Sloan Kettering's writing program, Visible Ink.
Molly Freeman explains why it is necessary for providers to be educated on stereotactic body radiation therapy.
The National LGBT Cancer Network's research found that, compared with other survivors, lesbian, gay, bisexual, and transgender individuals often have some striking differences in who they turn to for support during cancer treatment.
While most health care providers and medical practitioners are aware of the significant limitations HIPAA places on their activities, they are less clear how to react when it’s the patient who wants to record the physician, which could potentially expose protected health information of other patients.
Patients with the highest risk of developing a BRCA mutation are not being tested earlier enough and developing these mutations when it's too late. Clinicians can change that.
More than anything, I want to be a part of finding a cure for lung cancer and many other cancers-not just for me, but also for my children, their children, and all our future generations.
Once a terminal illness, HIV is now considered a chronic disease due to the advances in highly active antiretroviral treatment (HAART).
Rapid changes occurring nationally and worldwide—including shifts in demographics, languages, epidemiological patterns, and social systems— have direct implications for patient care. These trends are projected to continue, and nurses need to be prepared to care for increasingly diverse patient populations.
Members of the IHadCancer community give their insghts on what friends and family should know when sharing the holidays with a patient with cancer.
Dana Bushman, a certified yoga instructor, provides advice for a patient with cancer beginning yoga.
Oncology nurses are an important resource for patients with cancer when dealing with adverse effects that can be disruptive to quality of life.
Mark D. Duncan, MD, from The Johns Hopkins University School of Medicine, discusses demonstrable metrics that help measure the success of a patient navigation program.
In 2010, Smilow Cancer Hospital (SCH) at Yale New Haven and Yale Cancer Center (YCC) transitioned from a multisite cancer care delivery system that was both university- and hospitalbased to a new, state-of-the-art, 14-story comprehensive cancer center building.
Erin W. Hofstatter, MD, assistant professor of medicine (medical oncology), co-director, Genetic Counseling Program, Yale Cancer Center, discusses chemoprevention to reduce one's risk of developing breast cancer.
METAvivor is dedicated to the specific fight of women and men living with stage 4 metastatic breast cancer.
Andrew M. Kaunitz, MD, FACOG, professor, Associate Chair, Department of Obstetrics and Gynecology, University of Florida College of Medicine - Jacksonville, provides an overview of bioidentical hormone therapy.
Virginia Martin, RN, MSN, AOCN, Clinical Director for Ambulatory Care at Fox Chase Cancer Center, discusses the collaboration between the cancer center and the Pennsylvania Career and Technical Education program.
Steve Pake, a testicular cancer survivors gives some insight as April is testicular cancer awareness month.
Nurses are there for patients every step of the way.
Wells A. Messersmith, MD, co-director of the developmental therapeutics program at the University of Colorado Cancer Center, said work in this area is needed to fill the knowledge gaps in metastatic CRC, which has a 5-year survival rate of just 11%.
When treating patients with prostate cancer in survivorship care, Dan Spratt underscores the importance of being aware of potential mental health issues.
Dr. Beth DuPree from Holy Redeemer Health System Provides Z11 Trial Takeaway Points
Researchers tested a meditation app that addresses the work stressors of oncology professional healthcare providers.